Non-small cell lung cancer (NSCLC)
CA240-0009
A Phase 2 Trial of BMS-986504 in Participants with Advanced and or Metastatic Non-Small Cell Lung Cancer with Homozygous MTAP Deletion After Progression on Prior Therapies
Trial overview
Clinical Area
Medical Oncology
Disease
Non-small cell lung cancer
Disease site
Lung & Bronchus
Study Phase
II
Trial Identifiers
Registration number: NCT06855771
GenesisCare Location(s)
Principal Investigator(s)
Clinical trials enquiries